ANO1 and prostate carcinoma: Adding support to the idea that ANO1 expression is epigenetically regulated, 5-Aza-CdR treatment generates the hypomethylation of ANO1 CpG islands and the active state of ANO1 gene expression in LNCap/DU145 prostate cancer cells and xenograft models.